Overview

Clinical Trial to Assess Efficacy of cYclosporine Plus Standard of Care in Hospitalized Patients With COVID19

Status:
Completed
Trial end date:
2021-03-31
Target enrollment:
Participant gender:
Summary
The study hypothesis is that cyclosporine, added to standard treatment of hospitalized patients with COVID19 infection may improve their prognosis.
Phase:
Phase 4
Details
Lead Sponsor:
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz
Treatments:
Cyclosporine
Cyclosporins